{
    "2019-06-20": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Drugs Under FDA Review With Blockbuster Potential",
                "features": {
                    "keywords": [
                        "Drugs",
                        "FDA",
                        "Review",
                        "Blockbuster"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie Declares Quarterly Dividend",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Quarterly",
                        "Dividend"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Is AbbVie (ABBV) a Great Value Stock Right Now?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Value",
                        "Stock"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "These New Product Launches Could Partially Offset Humiraâ€™s Losses",
                "features": {
                    "keywords": [
                        "New",
                        "Product",
                        "Launches",
                        "Humira",
                        "Losses"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}